Jessica Liegel

4PUBLICATIONS
42CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

|Aug 14, 2025
Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia.

Jessica Liegel, Dina Stroopinsky, Giulia Cheloni

|Jun 03, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma.

Sundar Jagannath, Thomas G Martin, Yi Lin

|Oct 07, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.

Marlise R Luskin, Mark A Murakami, Julia Keating

Pageof 1

Frequent Collaborators

2 joint publications

Andrzej J Jakubowiak

1 joint publications

Sundar Jagannath

1 joint publications

Yi Lin

1 joint publications

Adam D Cohen